Regulatory guidance / GMP guideline
EMA computerised systems in clinical trials
Sponsors, investigators and service providers using computerised systems and electronic data in clinical trials.
Open official sourceDoes this apply to my work?
Apply within the clinical-trial role and governing requirements; a GMP or device-production assessment is not automatically transferable.
The document states: six months after publication.
What does it address?
Addresses trial data integrity, responsibilities and system controls.
What does this mean in practice?
The controls and evidence below are practitioner examples. They are not mandatory document names or a complete list of obligations.
| Source provision | Requirement or recommendation | Practical control or activity | Example evidence | Applicability note |
|---|---|---|---|---|
| Data integrity and responsibilities | Clinical-trial guideline expectation | Assign responsibility for data, system operation and provider oversight. | Responsibility agreement and evidence of system and data checks. | Define sponsor, investigator and service-provider duties for the trial. |
Illustrative example
A decision in practice
- Intended use
- A sponsor receives electronic outcome data through a service provider.
- Risk
- A transfer could lose metadata needed to interpret the result.
- Control
- Agree data responsibilities and retain the necessary context.
- Testing
- Reconcile transferred records and challenge missing or altered metadata.
- Evidence
- Transfer reconciliation, validation observations and issue resolution.
- Conclusion
- The illustrative team accepts the transfer only when the relevant data and context remain interpretable.
More practitioner context
Practical impact
Clinical-system assessments should cover system inventory, fitness for purpose, interfaces, operational responsibility, data integrity, access, and documented procedures.
Actions to consider
Use the guideline within the actual clinical-trial role and legal context; identify additional device, privacy, signature, or national requirements separately.
Practitioner interpretation
Do not transfer a GMP or medical-device validation conclusion into a GCP context without reassessing the applicable process and record obligations.
Continuing context
It does not replace the governing clinical-trial legislation, ICH GCP, or other applicable legal frameworks.
Source and review information
Source check: 21 September 2026. Publication identity, scope and status checked against the linked official source. This is not an independent audit of every retained guide statement.
Citation, dates and editorial history
- Stable source ID
- ema-computerised-systems-clinical-trials
- Official citation
- Guideline on computerised systems and electronic data in clinical trials
- Issuing organization
- European Medicines Agency
- Edition
- EMA/INS/GCP/112288/2023
- Publication
- Document dated 9 March 2023; adopted 7 March 2023
- Application / transition
- The document states: six months after publication.
- Publication status
- Final / published
- Verification
- Verified — public source metadata and scope
- Editorial update
- 21 September 2026 · Version 2.0
- Source owner
- CSVtoCSA editorial
- Review needed
- Recheck when the source or intended use changes
- Independent review
- No independent regulatory review is claimed.
- Earlier publication
- EMA/INS/GCP/454280/2010 reflection paper on electronic source data, explicitly replaced by this guideline.
- Prior editorial date
- 12 September 2026 (existing record or detailed guide)
21 September 2026: Source metadata checked, scope clarified, practical mapping and illustrative example added, and layout reorganized. Existing detailed guide content and its dated history are retained below its disclosure. This is an editorial update, not a regulatory amendment.
Questions and corrections
Contributor opinions are moderated and remain distinct from the source and site explanation. Comments do not update source metadata.
Suggest a source correction
Sent privately to the editorial moderation queue. Your account email and correction are not published as a comment. Do not include confidential or personal information.
Source: ema-computerised-systems-clinical-trials
Loading sign-in status…
Ask a question or share a professional example
Questions and discussion
Ask a question or share a perspective. Contributions are reviewed before publication.
Loading contribution options…